7 results
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... #Profiles #SideEffects ... #Table #DecisionAid ... #Orals #DM2 #Diabetes ... #Endocrinology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Each class of medications ... pharmacotherapy #table ... comparison #management #medications ... #diabetes #endocrinology ... #treatment
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... The optimal TTR ... #pharmacology #treatment ... #medications #table ... pharmacotherapy #decisionaid
Pituitary Mass Effects - Pathogenesis and Clinical Findings
 • Pituitary turnors are almost always a benign
adenomas that require treatment ... targeted with medication ... Hyperprolactinemia • Diabetes ... #Macroadenoma #SideEffects ... #endocrinology
Optimal glycemic control is fundamental to the management of diabetes.

A1C% measurement approximately every 3 months determines
management of diabetes ... situation, the treatment ... #management #endocrinology ... #diabetes #decisionaid ... #treatment #table
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
Etiology: • Medications ... Elimination (see Table ... STOP offending medications ... Redistribution Treatments ... #potassium #nephrology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
• Nephrogenic diabetes ... Tolvaptan) • Treatment ... Excretion #Diuresis #Nephrology ... #Pharmacology #Medications ... #Table